Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
K Li, W Chen, L Ma, L Yan, B Wang - Environmental Research, 2023 - Elsevier
Nanoparticles are fascinating and encouraging carriers for cancer treatment due to their
extraordinary properties and potential applications in targeted drug delivery, treatment, and …
extraordinary properties and potential applications in targeted drug delivery, treatment, and …
Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy
X Su, X Zhang, W Liu, X Yang, N An, F Yang… - Seminars in Cancer …, 2022 - Elsevier
Advances in the development of anti-tumour drugs and related technologies have resulted
in a significant increase in the number of cancer survivors. However, the incidence of …
in a significant increase in the number of cancer survivors. However, the incidence of …
Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity
X Luo - Environmental Research, 2023 - Elsevier
The cardiovascular diseases have been among the most common malignancies and the first
leading cause of death, even higher than cancer. The cardiovascular diseases can be …
leading cause of death, even higher than cancer. The cardiovascular diseases can be …
Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?
Y Jiang, Y Jiang, M Li, Q Yu - Frontiers in Pharmacology, 2023 - frontiersin.org
Cancer is one of the leading causes of death worldwide, and with the continuous
development of life sciences and pharmaceutical technology, more and more antitumor …
development of life sciences and pharmaceutical technology, more and more antitumor …
Reduction of doxorubicin-induced cardiotoxicity using nanocarriers: a review
M Fojtu, J Gumulec, T Stracina… - Current drug …, 2017 - ingentaconnect.com
Background: Anthracycline antibiotic doxorubicin (DOX) is a very potent and extensively
prescribed chemotherapeutic drug. It is widely utilized in the therapy of variety of …
prescribed chemotherapeutic drug. It is widely utilized in the therapy of variety of …
Nanoparticles toxicity: An overview of its mechanism and plausible mitigation strategies
Over the last decade, nanoparticles have found great interest among scientists and
researchers working in various fields within the realm of biomedicine including drug …
researchers working in various fields within the realm of biomedicine including drug …
Toxicity of novel nanosized formulations used in medicine
A El-Ansary, S Al-Daihan, AB Bacha, M Kotb - Oxidative Stress and …, 2013 - Springer
Nanotechnology involves the creation and manipulation of materials at nanoscale levels (1–
100 nm) to create products that exhibit novel properties. While this motivation has driven …
100 nm) to create products that exhibit novel properties. While this motivation has driven …
Cardiotoxicity of nano-particles
Nano-particles (NPs) are used in industrial and biomedical fields such as cosmetics, food
additives and biosensors. Beside their favorable properties, nanoparticles are responsible …
additives and biosensors. Beside their favorable properties, nanoparticles are responsible …
Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems
A Sharma, SRV Madhunapantula… - Expert opinion on drug …, 2012 - Taylor & Francis
Introduction: The biggest challenge faced by the scientific community involved in drug
development is to deliver safe and effective dosage of drugs without causing systemic …
development is to deliver safe and effective dosage of drugs without causing systemic …
Toxicologic concerns with current medical nanoparticles
TM Cheng, HY Chu, HM Huang, ZL Li… - International journal of …, 2022 - mdpi.com
Nanotechnology is one of the scientific advances in technology. Nanoparticles (NPs) are
small materials ranging from 1 to 100 nm. When the shape of the supplied nanoparticles …
small materials ranging from 1 to 100 nm. When the shape of the supplied nanoparticles …